StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Squeeze coming

<< Previous

Bullboard Posts

Next >>

Comment by brad129on Apr 09, 2021 4:53pm

117 Views

Post# 32971134

RE:RE:RE:RE:RE:RE:RE:Squeeze coming

we will have more revenue from them, will also have more expense with them as well, question is which one will be greater? Do you happen to know their sales? Do you know what their net profit or loss was. Are we going to need to finance to support them as well. Lots of unanswered questions. By the way our sales just almost doubled, but here we are. 7million in the bank was end of December how much of that is still there? We were to expand to upto 3000 tests per day, we haven't hit the 1000 we had capacity a year ago. No one is talking about this stuff, so the simple pumps to the moon mean nothing.